Certain Women May Face Higher Risk for Second Breast Cancer Certain Women May Face Higher Risk for Second Breast Cancer
Young breast cancer survivors with a germline pathogenic variant or who are initially diagnosed with in situ disease have more than a fourfold higher risk for a second primary breast cancer.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 17, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
Microbial Signature of KRAS-Mutated CRC Identified Microbial Signature of KRAS-Mutated CRC Identified
Researchers analyzed gut microbiota from KRAS-mutated and KRAS wild-type colorectal cancer to assess the link between disruptions in the gut microbiome and KRAS mutations in the disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 17, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
New Agent Shows Early Promise in Triple-Class Refractory MM New Agent Shows Early Promise in Triple-Class Refractory MM
With linvoseltamab and other bispecific antibodies inducing deep and durable responses, there might finally be a go-to option for multiple myeloma patients resistant to mainstay treatments.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 17, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Most Targeted Cancer Drugs Lack Substantial Clinical Benefit Most Targeted Cancer Drugs Lack Substantial Clinical Benefit
Only a minority of genome-targeted cancer drugs recently approved in the United States demonstrate significant clinical benefits to patients, a new analysis found.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 16, 2024 Category: Consumer Health News Tags: Hematology-Oncology Clinical Summary Source Type: news
Don't Rule Out Breast Cancer Surgery for 90-Year-Olds
(MedPage Today) -- ORLANDO -- Primary breast cancer surgery for nonagenarians in good physical shape was associated with improved survival compared with a non-surgical approach, retrospective data from a single center in Italy showed.
Among... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 15, 2024 Category: Hematology Source Type: news
Cryoablation for Early-Stage Breast Cancer a Safe Option in Older Women
(MedPage Today) -- ORLANDO -- Cryoablation without excision for low-risk, early-stage breast cancer may be an option for women over 60, 5-year follow-up results from the ICE3 trial showed.
At a mean follow-up of 54.2 months, the ipsilateral... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 15, 2024 Category: Hematology Source Type: news
ALL: Which Life-Saving Tx Is Best? ALL: Which Life-Saving Tx Is Best?
New treatments like bispecific antibodies and CAR T-cell therapy have helped many patients with relapsed/refractory acute lymphoblastic leukemia live longer but which is best?MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 15, 2024 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
Monitoring ctDNA Predicts HER2+ Cancer Treatment Response Monitoring ctDNA Predicts HER2+ Cancer Treatment Response
Tracking a patient ' s circulating tumor DNA (ctDNA) can offer insight into how well-targeted therapies work in the early stages of treatment for HER2-positive cancers.MDedge News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 15, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news
Is Axillary Surgery in Early Breast Cancer on Its Way Out? Is Axillary Surgery in Early Breast Cancer on Its Way Out?
Omitting axillary surgery in patients with early breast cancer who had sentinel-node metastases and underwent surgery and radiotherapy did not compromise survival outcomes, new data show.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 15, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
Review Suggests Skin AEs Rare With PD-1/PD-L1 Inhibitors Review Suggests Skin AEs Rare With PD-1/PD-L1 Inhibitors
Reports of keratoacanthomas and squamous cell carcinomas associated with the use of PD-1/PD-L1 inhibitors appeared to be relatively rare.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 15, 2024 Category: Cancer & Oncology Tags: Dermatology Clinical Summary Source Type: news
Journey Into Virtual Reality Eases Cancer Pain
(MedPage Today) -- Immersive virtual reality (VR) as distraction therapy provided relief for hospitalized cancer patients with moderate to severe pain, a single-center randomized trial showed.
Among patients with pain related to their malignancy... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 12, 2024 Category: Hematology Source Type: news
Will AI Clinical Notes Benefit Your Practice? Will AI Clinical Notes Benefit Your Practice?
Artificial intelligence expert Arturo Loaiza-Bonilla, MD, discusses the benefits of AI-based clinical notes.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news
Riding the 'Boob Bus'; Prior Authorization Pushback; Cancer Warning for Alcohol?
(MedPage Today) -- "The Boob Bus" -- An entrepreneur turns mammography into a road show. (Lassonde Entrepreneur Institute, University of Utah)
Radiation therapy before mastectomy for breast cancer reduced delays in reconstructive surgery. (University... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - April 12, 2024 Category: Hematology Source Type: news
Weighing the Balance: Immunotherapy for Cancer Treatment Weighing the Balance: Immunotherapy for Cancer Treatment
Prof David Kerr discusses immunotherapy for the treatment of cancer and the importance of considering the risks and benefits of treatment.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 12, 2024 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news
Oncologists Voice Ethical Concerns Over AI in Cancer Care Oncologists Voice Ethical Concerns Over AI in Cancer Care
A survey of oncologists highlighted ethical issues over the use of AI in cancer care and revealed some contradictory views about how best to integrate these tools.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - April 12, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Clinical Summary Source Type: news
